Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

Dipak Kotecha; Katherine Ngo; Julia A E Walters; Luis Manzano; Alberto Palazzuoli; Marcus D Flather

doi:10.1016/j.ahj.2011.02.013

Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

Dipak Kotecha, Katherine Ngo, Julia A E Walters, Luis Manzano, Alberto Palazzuoli, Marcus D Flather

Cardiovascular Sciences

Research output: Contribution to journal › Article › peer-review

54 Citations (Scopus)

11 Downloads (Pure)

Abstract

Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.

Original language	English
Pages (from-to)	822-831
Journal	American Heart Journal
Volume	161
Issue number	5
Early online date	12 May 2011
DOIs	https://doi.org/10.1016/j.ahj.2011.02.013
Publication status	Published - May 2011

Keywords

Anemia
Erythropoietin
Heart Failure
Humans
Randomized Controlled Trials as Topic
Treatment Outcome

Access to Document

10.1016/j.ahj.2011.02.013Licence: None: All rights reserved

Cite this

@article{e3a9f14d28ea419f87a46837848afc73,

title = "Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials",

abstract = "Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.",

keywords = "Anemia, Erythropoietin, Heart Failure, Humans, Randomized Controlled Trials as Topic, Treatment Outcome",

author = "Dipak Kotecha and Katherine Ngo and Walters, {Julia A E} and Luis Manzano and Alberto Palazzuoli and Flather, {Marcus D}",

year = "2011",

month = may,

doi = "10.1016/j.ahj.2011.02.013",

language = "English",

volume = "161",

pages = "822--831",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Erythropoietin as a treatment of anemia in heart failure

T2 - systematic review of randomized trials

AU - Kotecha, Dipak

AU - Ngo, Katherine

AU - Walters, Julia A E

AU - Manzano, Luis

AU - Palazzuoli, Alberto

AU - Flather, Marcus D

PY - 2011/5

Y1 - 2011/5

N2 - Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.

AB - Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.

KW - Anemia

KW - Erythropoietin

KW - Heart Failure

KW - Humans

KW - Randomized Controlled Trials as Topic

KW - Treatment Outcome

U2 - 10.1016/j.ahj.2011.02.013

DO - 10.1016/j.ahj.2011.02.013

M3 - Article

C2 - 21570510

SN - 0002-8703

VL - 161

SP - 822

EP - 831

JO - American Heart Journal

JF - American Heart Journal

IS - 5

ER -

Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

Abstract

Keywords

Access to Document

Fingerprint

Cite this